1. Zhou, Jian, Zheng, Housheng, Zhang, Huiru, Ye, Liang, Wang, Lu. 2024. MCM5 is a Novel Therapeutic Target for Glioblastoma. In OncoTargets and therapy, 17, 371-381. doi:10.2147/OTT.S457600. https://pubmed.ncbi.nlm.nih.gov/38765057/
2. Mao, Jiayan, Shen, Jian, Lu, Xuemei, Wu, Yuan, Chen, Wei. 2023. MCM5 is an oncogene of colon adenocarcinoma and promotes progression through cell cycle control. In Acta histochemica, 125, 152072. doi:10.1016/j.acthis.2023.152072. https://pubmed.ncbi.nlm.nih.gov/37385108/
3. Wang, Shuming, Wu, Weiqin, Han, Xiang. 2022. Enhanced MCM5 Level Predicts Bad Prognosis in Acute Myeloid Leukemia. In Molecular biotechnology, 65, 1242-1252. doi:10.1007/s12033-022-00623-9. https://pubmed.ncbi.nlm.nih.gov/36479666/
4. Mio, Catia, Lavarone, Elisa, Conzatti, Ketty, Di Loreto, Carla, Damante, Giuseppe. 2016. MCM5 as a target of BET inhibitors in thyroid cancer cells. In Endocrine-related cancer, 23, 335-47. doi:10.1530/ERC-15-0322. https://pubmed.ncbi.nlm.nih.gov/26911376/
5. Eissa, Sanaa, Matboli, Marwa, Shehata, Hanan H, Essawy, Nada O E. 2015. MicroRNA-10b and minichromosome maintenance complex component 5 gene as prognostic biomarkers in breast cancer. In Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 36, 4487-94. doi:10.1007/s13277-015-3090-2. https://pubmed.ncbi.nlm.nih.gov/25596707/
6. Wang, Dan, Li, Qian, Li, Yichun, Wang, Hongyan. 2017. The role of MCM5 expression in cervical cancer: Correlation with progression and prognosis. In Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 98, 165-172. doi:10.1016/j.biopha.2017.12.006. https://pubmed.ncbi.nlm.nih.gov/29253764/
智鼠故事 
